Astrana Health (ASTH) Liabilities and Shareholders Equity (2011 - 2026)

Astrana Health has disclosed Liabilities and Shareholders Equity across 16 years of filings, most recently posting $2.4 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $2.4 billion, up 77.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.3 billion (up 58.06% YoY), and the FY2025 annual result was $2.2 billion, up 63.75% from the prior year.
• Liabilities and Shareholders Equity came in at $2.4 billion for Q1 2026 at Astrana Health, up from $2.2 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.4 billion in Q1 2026 to a low of $922.7 million in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $1.2 billion (2024), against an average of $1.3 billion.
• Across the five-year window, Liabilities and Shareholders Equity declined 3.4% in 2023 and surged 77.19% in 2026, its largest moves.
• Astrana Health's Liabilities and Shareholders Equity stood at $966.2 million in 2022, then slipped by 3.4% to $933.4 million in 2023, then surged by 45.16% to $1.4 billion in 2024, then soared by 63.75% to $2.2 billion in 2025, then increased by 6.32% to $2.4 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $2.4 billion (Q1 2026), $2.2 billion (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.